Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Exercise or conversion Sr. VP & CSO acquired 13,693 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Treasurer and CFO sold 6,000 shares at $45.58 ($273,463)
  12. 4 Shares withheld for taxes Sr. VP & General Counsel gave up 1,540 shares (to pay taxes)
  13. 4 Shares withheld for taxes Treasurer and CFO gave up 770 shares (to pay taxes)
  14. 4 Shares withheld for taxes Sr. VP & Chief Medical Officer gave up 1,540 shares (to pay taxes)
  15. 4 Shares withheld for taxes Sr. VP & CSO gave up 1,540 shares (to pay taxes)
  16. 4 Shares withheld for taxes President and CEO gave up 2,201 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Exercise or conversion Sr. VP & General Counsel acquired 1,667 shares (option exercise)
  20. 4 Grant or award Sr. VP & General Counsel acquired 7,600 shares (grant or award)

Page 10 of 24 · 475 filings